-
1
-
-
48749123878
-
Prognostic implications of gene mutations in acute myeloid leukemia with normal cytogenetics
-
Gaidzik V, Döhner K: Prognostic implications of gene mutations in acute myeloid leukemia with normal cytogenetics. Semin Oncol 35:346-355, 2008
-
(2008)
Semin Oncol
, vol.35
, pp. 346-355
-
-
Gaidzik, V.1
Döhner, K.2
-
3
-
-
33846230449
-
Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: Are we ready for a prognostically prioritized molecular classification?
-
Mrózek K, Marcucci G, Paschka P, et al: Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: Are we ready for a prognostically prioritized molecular classification? Blood 109:431-448, 2007
-
(2007)
Blood
, vol.109
, pp. 431-448
-
-
Mrózek, K.1
Marcucci, G.2
Paschka, P.3
-
4
-
-
0037097716
-
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: Association with FAB subtypes and identification of subgroups with poor prognosis
-
Thiede C, Steudel C, Mohr B, et al: Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: Association with FAB subtypes and identification of subgroups with poor prognosis. Blood 99:4326-4335, 2002
-
(2002)
Blood
, vol.99
, pp. 4326-4335
-
-
Thiede, C.1
Steudel, C.2
Mohr, B.3
-
5
-
-
0035476264
-
Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: A Cancer and Leukemia Group B study
-
Whitman SP, Archer KJ, Feng L, et al: Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: A Cancer and Leukemia Group B study. Cancer Res 61:7233-7239, 2001
-
(2001)
Cancer Res
, vol.61
, pp. 7233-7239
-
-
Whitman, S.P.1
Archer, K.J.2
Feng, L.3
-
6
-
-
28444473100
-
Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: Interaction with other gene mutations
-
Döhner K, Schlenk RF, Habdank M, et al: Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: Interaction with other gene mutations. Blood 106:3740-3746, 2005
-
(2005)
Blood
, vol.106
, pp. 3740-3746
-
-
Döhner, K.1
Schlenk, R.F.2
Habdank, M.3
-
7
-
-
19944427850
-
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype
-
Falini B, Mecucci C, Tiacci E, et al: Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 352:254-266, 2005
-
(2005)
N Engl J Med
, vol.352
, pp. 254-266
-
-
Falini, B.1
Mecucci, C.2
Tiacci, E.3
-
8
-
-
1442356729
-
CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: Prognostic relevance and analysis of cooperating mutations
-
Fröhling S, Schlenk RF, Stolze I, et al: CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: Prognostic relevance and analysis of cooperating mutations. J Clin Oncol 22:624-633, 2004
-
(2004)
J Clin Oncol
, vol.22
, pp. 624-633
-
-
Fröhling, S.1
Schlenk, R.F.2
Stolze, I.3
-
9
-
-
55549103713
-
Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: A Cancer and Leukemia Group B study
-
Marcucci G, Maharry K, Radmacher MD, et al: Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: A Cancer and Leukemia Group B study. J Clin Oncol 26:5078-5087, 2008
-
(2008)
J Clin Oncol
, vol.26
, pp. 5078-5087
-
-
Marcucci, G.1
Maharry, K.2
Radmacher, M.D.3
-
10
-
-
53749101166
-
Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: A Cancer and Leukemia Group B study
-
Paschka P, Marcucci G, Ruppert AS, et al: Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: A Cancer and Leukemia Group B study. J Clin Oncol 26:4595-4602, 2008
-
(2008)
J Clin Oncol
, vol.26
, pp. 4595-4602
-
-
Paschka, P.1
Marcucci, G.2
Ruppert, A.S.3
-
11
-
-
56749098118
-
Mutation of the Wilms' tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: The United Kingdom Medical Research Council Adult Leukaemia Working Party
-
Virappane P, Gale R, Hills R, et al: Mutation of the Wilms' tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: The United Kingdom Medical Research Council Adult Leukaemia Working Party. J Clin Oncol 26:5429-5435, 2008
-
(2008)
J Clin Oncol
, vol.26
, pp. 5429-5435
-
-
Virappane, P.1
Gale, R.2
Hills, R.3
-
12
-
-
0031984414
-
Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics
-
Caligiuri MA, Strout MP, Lawrence D, et al: Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. Cancer Res 58:55-59, 1998
-
(1998)
Cancer Res
, vol.58
, pp. 55-59
-
-
Caligiuri, M.A.1
Strout, M.P.2
Lawrence, D.3
-
13
-
-
34250011216
-
Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: A Cancer and Leukemia Group B study
-
Whitman SP, Ruppert AS, Marcucci G, et al: Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: A Cancer and Leukemia Group B study. Blood 109:5164-5167, 2007
-
(2007)
Blood
, vol.109
, pp. 5164-5167
-
-
Whitman, S.P.1
Ruppert, A.S.2
Marcucci, G.3
-
14
-
-
77952536841
-
IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: A Cancer and Leukemia Group B study
-
Marcucci G, Maharry K, Wu YZ, et al: IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: A Cancer and Leukemia Group B study. J Clin Oncol 28:2348-2355, 2010
-
(2010)
J Clin Oncol
, vol.28
, pp. 2348-2355
-
-
Marcucci, G.1
Maharry, K.2
Wu, Y.Z.3
-
15
-
-
77955907891
-
IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication
-
Paschka P, Schlenk RF, Gaidzik VI, et al: IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication. J Clin Oncol 28:3636-3643, 2010
-
(2010)
J Clin Oncol
, vol.28
, pp. 3636-3643
-
-
Paschka, P.1
Schlenk, R.F.2
Gaidzik, V.I.3
-
16
-
-
79954428737
-
TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: A Cancer and Leukemia Group B study
-
Metzeler KH, Maharry K, Radmacher MD, et al: TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: A Cancer and Leukemia Group B study. J Clin Oncol 29:1373-1381, 2011
-
(2011)
J Clin Oncol
, vol.29
, pp. 1373-1381
-
-
Metzeler, K.H.1
Maharry, K.2
Radmacher, M.D.3
-
17
-
-
77449159028
-
Diagnosis and management of acute myeloid leukemia in adults: Recommendations from an international expert panel, on behalf of the European LeukemiaNet
-
Döhner H, Estey EH, Amadori S, et al: Diagnosis and management of acute myeloid leukemia in adults: Recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 115:453-474, 2010
-
(2010)
Blood
, vol.115
, pp. 453-474
-
-
Döhner, H.1
Estey, E.H.2
Amadori, S.3
-
18
-
-
77449140390
-
Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: A Cancer and Leukemia Group B study
-
Becker H, Marcucci G, Maharry K, et al: Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: A Cancer and Leukemia Group B study. J Clin Oncol 28:596-604, 2010
-
(2010)
J Clin Oncol
, vol.28
, pp. 596-604
-
-
Becker, H.1
Marcucci, G.2
Maharry, K.3
-
19
-
-
0030061554
-
AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis
-
Okuda T, van Deursen J, Hiebert SW, et al: AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84:321-330, 1996
-
(1996)
Cell
, vol.84
, pp. 321-330
-
-
Okuda, T.1
Van Deursen, J.2
Hiebert, S.W.3
-
20
-
-
0037082499
-
In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: Implications for mechanisms of pathogenesis
-
Michaud J, Wu F, Osato M, et al: In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: Implications for mechanisms of pathogenesis. Blood 99:1364-1372, 2002
-
(2002)
Blood
, vol.99
, pp. 1364-1372
-
-
Michaud, J.1
Wu, F.2
Osato, M.3
-
21
-
-
0032830638
-
Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia
-
Song WJ, Sullivan MG, Legare RD, et al: Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet 23:166-175, 1999
-
(1999)
Nat Genet
, vol.23
, pp. 166-175
-
-
Song, W.J.1
Sullivan, M.G.2
Legare, R.D.3
-
22
-
-
1542373639
-
High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia
-
Harada H, Harada Y, Niimi H, et al: High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia. Blood 103:2316-2324, 2004
-
(2004)
Blood
, vol.103
, pp. 2316-2324
-
-
Harada, H.1
Harada, Y.2
Niimi, H.3
-
23
-
-
34848824979
-
RUNX1 gene mutation in primary myelodysplastic syndrome: The mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome
-
Chen CY, Lin LI, Tang JL, et al: RUNX1 gene mutation in primary myelodysplastic syndrome: The mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome. Br J Haematol 139:405-414, 2007
-
(2007)
Br J Haematol
, vol.139
, pp. 405-414
-
-
Chen, C.Y.1
Lin, L.I.2
Tang, J.L.3
-
24
-
-
0034667690
-
High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2αB gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21
-
Preudhomme C, Warot-Loze D, Roumier C, et al: High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2αB gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21. Blood 96:2862-2869, 2000
-
(2000)
Blood
, vol.96
, pp. 2862-2869
-
-
Preudhomme, C.1
Warot-Loze, D.2
Roumier, C.3
-
25
-
-
0037441589
-
M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: A report of 59 cases by the Groupe Français d'Hé matologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH)
-
Roumier C, Eclache V, Imbert M, et al: M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: A report of 59 cases by the Groupe Français d'Hé matologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH). Blood 101:1277-1283, 2003
-
(2003)
Blood
, vol.101
, pp. 1277-1283
-
-
Roumier, C.1
Eclache, V.2
Imbert, M.3
-
26
-
-
9144270483
-
Dual mutations in the AML1 and FLT3 genes are associated with leukemogenesis in acute myeloblastic leukemia of the M0 subtype
-
Matsuno N, Osato M, Yamashita N, et al: Dual mutations in the AML1 and FLT3 genes are associated with leukemogenesis in acute myeloblastic leukemia of the M0 subtype. Leukemia 17:2492-2499, 2003
-
(2003)
Leukemia
, vol.17
, pp. 2492-2499
-
-
Matsuno, N.1
Osato, M.2
Yamashita, N.3
-
27
-
-
0037473113
-
Identification of RUNX1/AML1 as a classical tumor suppressor gene
-
Silva FP, Morolli B, Storlazzi CT, et al: Identification of RUNX1/AML1 as a classical tumor suppressor gene. Oncogene 22:538-547, 2003
-
(2003)
Oncogene
, vol.22
, pp. 538-547
-
-
Silva, F.P.1
Morolli, B.2
Storlazzi, C.T.3
-
28
-
-
35748939738
-
Trisomy 13 correlates with RUNX1 mutation and increased FLT3 expression in AML-M0 patients
-
Silva FP, Lind A, Brouwer-Mandema G, et al: Trisomy 13 correlates with RUNX1 mutation and increased FLT3 expression in AML-M0 patients. Haematologica 92:1123-1126, 2007
-
(2007)
Haematologica
, vol.92
, pp. 1123-1126
-
-
Silva, F.P.1
Lind, A.2
Brouwer-Mandema, G.3
-
29
-
-
34548044732
-
Trisomy 13 is strongly associated with AML1/RUNX1 mutations and increased FLT3 expression in acute myeloid leukemia
-
Dicker F, Haferlach C, Kern W, et al: Trisomy 13 is strongly associated with AML1/RUNX1 mutations and increased FLT3 expression in acute myeloid leukemia. Blood 110:1308-1316, 2007
-
(2007)
Blood
, vol.110
, pp. 1308-1316
-
-
Dicker, F.1
Haferlach, C.2
Kern, W.3
-
30
-
-
0033559746
-
Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2αB gene associated with myeloblastic leukemias
-
Osato M, Asou N, Abdalla E, et al: Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2αB gene associated with myeloblastic leukemias. Blood 93:1817-1824, 1999
-
(1999)
Blood
, vol.93
, pp. 1817-1824
-
-
Osato, M.1
Asou, N.2
Abdalla, E.3
-
31
-
-
79952134550
-
RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis
-
Schnittger S, Dicker F, Kern W, et al: RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis. Blood 117:2348-2357, 2011
-
(2011)
Blood
, vol.117
, pp. 2348-2357
-
-
Schnittger, S.1
Dicker, F.2
Kern, W.3
-
32
-
-
79954448043
-
RUNX1 mutations in acute myeloid leukemia: Results from a comprehensive genetic and clinical analysis from the AML Study Group
-
Gaidzik VI, Bullinger L, Schlenk RF, et al: RUNX1 mutations in acute myeloid leukemia: Results from a comprehensive genetic and clinical analysis from the AML Study Group. J Clin Oncol 29:1364-1372, 2011
-
(2011)
J Clin Oncol
, vol.29
, pp. 1364-1372
-
-
Gaidzik, V.I.1
Bullinger, L.2
Schlenk, R.F.3
-
33
-
-
73949090504
-
AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: Prognostic implication and interaction with other gene alterations
-
Tang JL, Hou HA, Chen CY, et al: AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: Prognostic implication and interaction with other gene alterations. Blood 114:5352-5361, 2009
-
(2009)
Blood
, vol.114
, pp. 5352-5361
-
-
Tang, J.L.1
Hou, H.A.2
Chen, C.Y.3
-
34
-
-
0036009568
-
Mutations of the AML1 gene in acute myeloid leukemia of FAB types M0 and M7
-
Langabeer SE, Gale RE, Rollinson SJ, et al: Mutations of the AML1 gene in acute myeloid leukemia of FAB types M0 and M7. Genes Chromosomes Cancer 34:24-32, 2002
-
(2002)
Genes Chromosomes Cancer
, vol.34
, pp. 24-32
-
-
Langabeer, S.E.1
Gale, R.E.2
Rollinson, S.J.3
-
35
-
-
48749119622
-
Central review of cytogenetics is necessary for cooperative group correlative and clinical studies of adult acute leukemia: The Cancer and Leukemia Group B experience
-
Mrózek K, Carroll AJ, Maharry K, et al: Central review of cytogenetics is necessary for cooperative group correlative and clinical studies of adult acute leukemia: The Cancer and Leukemia Group B experience. Int J Oncol 33:239-244, 2008
-
(2008)
Int J Oncol
, vol.33
, pp. 239-244
-
-
Mrózek, K.1
Carroll, A.J.2
Maharry, K.3
-
36
-
-
38949212204
-
FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications
-
Whitman SP, Ruppert AS, Radmacher MD, et al: FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications. Blood 111:1552-1559, 2008
-
(2008)
Blood
, vol.111
, pp. 1552-1559
-
-
Whitman, S.P.1
Ruppert, A.S.2
Radmacher, M.D.3
-
37
-
-
13344249756
-
Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11
-
Caligiuri MA, Strout MP, Schichman SA, et al: Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11. Cancer Res 56:1418-1425, 1996
-
(1996)
Cancer Res
, vol.56
, pp. 1418-1425
-
-
Caligiuri, M.A.1
Strout, M.P.2
Schichman, S.A.3
-
38
-
-
84255176496
-
ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category
-
Metzeler KH, Becker H, Maharry K, et al: ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category. Blood 118:6920-6929, 2011
-
(2011)
Blood
, vol.118
, pp. 6920-6929
-
-
Metzeler, K.H.1
Becker, H.2
Maharry, K.3
-
39
-
-
84863116398
-
Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia
-
Marcucci G, Metzeler KH, Schwind S, et al: Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia. J Clin Oncol 30:742-750, 2012
-
(2012)
J Clin Oncol
, vol.30
, pp. 742-750
-
-
Marcucci, G.1
Metzeler, K.H.2
Schwind, S.3
-
40
-
-
80051663269
-
Pre-donor evaluation of an HLA matched sibling identifies a novel inherited RUNX1 mutation encoding a missense mutation found outside of the RUNT domain in familial platelet disorder
-
(abstr 2709)
-
Garcia JS, Madzo J, Cooper D, et al: Pre-donor evaluation of an HLA matched sibling identifies a novel inherited RUNX1 mutation encoding a missense mutation found outside of the RUNT domain in familial platelet disorder. Blood 116:1116-1117, 2010 (abstr 2709)
-
(2010)
Blood
, vol.116
, pp. 1116-1117
-
-
Garcia, J.S.1
Madzo, J.2
Cooper, D.3
-
41
-
-
3042820902
-
Microarray and serial analysis of gene expression analyses identify known and novel transcripts overexpressed in hematopoietic stem cells
-
Georgantas RW 3rd, Tanadve V, Malehorn M, et al: Microarray and serial analysis of gene expression analyses identify known and novel transcripts overexpressed in hematopoietic stem cells. Cancer Res 64:4434-4441, 2004
-
(2004)
Cancer Res
, vol.64
, pp. 4434-4441
-
-
Georgantas III, R.W.1
Tanadve, V.2
Malehorn, M.3
-
42
-
-
18744386948
-
Differential gene expression profiling of CD34+ CD133+ umbilical cord blood hematopoietic stem progenitor cells
-
He X, Gonzalez V, Tsang A, et al: Differential gene expression profiling of CD34+ CD133+ umbilical cord blood hematopoietic stem progenitor cells. Stem Cells Dev 14:188-198, 2005
-
(2005)
Stem Cells Dev
, vol.14
, pp. 188-198
-
-
He, X.1
Gonzalez, V.2
Tsang, A.3
-
43
-
-
0032803285
-
CD109 is expressed on a subpopulation of CD34+ cells enriched in hematopoietic stem and progenitor cells
-
Murray LJ, Bruno E, Uchida N, et al: CD109 is expressed on a subpopulation of CD34+ cells enriched in hematopoietic stem and progenitor cells. Exp Hematol 27:1282-1294, 1999
-
(1999)
Exp Hematol
, vol.27
, pp. 1282-1294
-
-
Murray, L.J.1
Bruno, E.2
Uchida, N.3
-
44
-
-
25444452414
-
CD133-positive hematopoietic stem cell "stemness" genes contain many genes mutated or abnormally expressed in leukemia
-
Toren A, Bielorai B, Jacob-Hirsch J, et al: CD133-positive hematopoietic stem cell "stemness" genes contain many genes mutated or abnormally expressed in leukemia. Stem Cells 23:1142-1153, 2005
-
(2005)
Stem Cells
, vol.23
, pp. 1142-1153
-
-
Toren, A.1
Bielorai, B.2
Jacob-Hirsch, J.3
-
45
-
-
80052468964
-
Stem cell gene expression programs influence clinical outcome in human leukemia
-
Eppert K, Takenaka K, Lechman ER, et al: Stem cell gene expression programs influence clinical outcome in human leukemia. Nat Med 17:1086-1093, 2011
-
(2011)
Nat Med
, vol.17
, pp. 1086-1093
-
-
Eppert, K.1
Takenaka, K.2
Lechman, E.R.3
-
46
-
-
78650444882
-
Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia
-
Gentles AJ, Plevritis SK, Majeti R, et al: Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. JAMA 304:2706-2715, 2010
-
(2010)
JAMA
, vol.304
, pp. 2706-2715
-
-
Gentles, A.J.1
Plevritis, S.K.2
Majeti, R.3
-
47
-
-
79953070487
-
Molecular resolution of the B cell landscape
-
Santos PM, Borghesi L: Molecular resolution of the B cell landscape. Curr Opin Immunol 23:163-170, 2011
-
(2011)
Curr Opin Immunol
, vol.23
, pp. 163-170
-
-
Santos, P.M.1
Borghesi, L.2
-
48
-
-
0041440085
-
BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: A Cancer and Leukemia Group B study
-
Baldus CD, Tanner SM, Ruppert AS, et al: BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: A Cancer and Leukemia Group B study. Blood 102:1613-1618, 2003
-
(2003)
Blood
, vol.102
, pp. 1613-1618
-
-
Baldus, C.D.1
Tanner, S.M.2
Ruppert, A.S.3
-
49
-
-
45949110015
-
High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: A Cancer and Leukemia Group B (CALGB) study
-
Langer C, Radmacher MD, Ruppert AS, et al: High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: A Cancer and Leukemia Group B (CALGB) study. Blood 111:5371-5379, 2008
-
(2008)
Blood
, vol.111
, pp. 5371-5379
-
-
Langer, C.1
Radmacher, M.D.2
Ruppert, A.S.3
-
50
-
-
67650312343
-
Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: A Cancer and Leukemia Group B study
-
Langer C, Marcucci G, Holland KB, et al: Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: A Cancer and Leukemia Group B study. J Clin Oncol 27:3198-3204, 2009
-
(2009)
J Clin Oncol
, vol.27
, pp. 3198-3204
-
-
Langer, C.1
Marcucci, G.2
Holland, K.B.3
-
51
-
-
50549095181
-
Let-7 microRNAs in development, stem cells and cancer
-
Büssing I, Slack FJ, Grosshans H: Let-7 microRNAs in development, stem cells and cancer. Trends Mol Med 14:400-409, 2008
-
(2008)
Trends Mol Med
, vol.14
, pp. 400-409
-
-
Büssing, I.1
Slack, F.J.2
Grosshans, H.3
-
52
-
-
28344438648
-
A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPα regulates human granulopoiesis
-
Fazi F, Rosa A, Fatica A, et al: A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPα regulates human granulopoiesis. Cell 123:819-831, 2005
-
(2005)
Cell
, vol.123
, pp. 819-831
-
-
Fazi, F.1
Rosa, A.2
Fatica, A.3
-
53
-
-
47749117212
-
Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia
-
Dixon-McIver A, East P, Mein CA, et al: Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PLoS One 3:e2141, 2008
-
(2008)
PLoS One
, vol.3
-
-
Dixon-McIver, A.1
East, P.2
Mein, C.A.3
-
54
-
-
84865763332
-
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia
-
Schlenk RF, Döhner K, Krauter J, et al: Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med 358: 1909-1918, 2008
-
(1909)
N Engl J Med 358
, vol.2008
-
-
Schlenk, R.F.1
Döhner, K.2
Krauter, J.3
-
55
-
-
2942667930
-
Point mutations in the RUNX1/AML1 gene: Another actor in RUNX leukemia
-
Osato M: Point mutations in the RUNX1/AML1 gene: Another actor in RUNX leukemia. Oncogene 23:4284-4296, 2004
-
(2004)
Oncogene
, vol.23
, pp. 4284-4296
-
-
Osato, M.1
-
56
-
-
70449429509
-
Gene expression profiling of minimally differentiated acute myeloid leukemia: M0 is a distinct entity subdivided by RUNX1 mutation status
-
Silva FP, Swagemakers SM, Erpelinck-Verschueren C, et al: Gene expression profiling of minimally differentiated acute myeloid leukemia: M0 is a distinct entity subdivided by RUNX1 mutation status. Blood 114:3001-3007, 2009
-
(2009)
Blood
, vol.114
, pp. 3001-3007
-
-
Silva, F.P.1
Swagemakers, S.M.2
Erpelinck-Verschueren, C.3
|